EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings

Benyam Muluneh iD, Michele A Muir iD, James Bernard Collins, Darrian Proco, Emily Mackler, Ashley Leak Bryant iD, William A Wood, Michael Tilkens, Jeffrey S Reichard, Matthew Foster, Justin Gatwood, Stephanie B Wheeler und 2 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Benyam Muluneh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, Nor…. Hauptthemen laut MEDLINE: Physicians, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The goal of this study is to determine barriers and facilitators to the implementation of medication adherence interventions to support cancer patients taking novel, targeted oral anticancer agents (OAAs).

Methods

We conducted qualitative interviews using a semi-structured guide from the Consolidated Framework for Implementation Research (CFIR). We used purposive sampling to identify clinicians (physicians, pharmacists, nurse practitioners, nurses) and administrators (leadership from medicine, pharmacy, and nursing) who delivered care and/or oversee care delivery for patients with chronic leukemia prescribed an OAA.

Results

A total of 19 individuals participated in an interview (12 clinicians and 7 administrators), with 10 primarily employed by an academic cancer center; 5 employed by the community cancer center; and 4 employed by the integrated health-system specialty pharmacy. Barriers identified included low awareness of adherence interventions, difficulty in adherence measurement, complexity of designing and implementing a structured adherence intervention, and competing priorities. Facilitators identified included support of hospital administrators, value for pharmacists, and willingness to embrace change. Participants also made recommendations moving forward including standardizing workflow, designating champions, iterating implementation strategies, and improving communication between clinicians and with patients.

Conclusion

Individual and system level factors were identified as determinants of implementation effectiveness of medication adherence interventions. A multidisciplinary advisory panel will be assembled to design comprehensive and actionable strategies to refine and implement a structured intervention to improve medication adherence in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhysiciansNeoplasmsAntineoplastic AgentsHumansDelivery of Health CarePharmacistsCommunicationQualitative Research

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Michigan Oncology Quality Consortium, Ann Arbor, MI, United States of America.
  • School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Department of Pharmacy, University of North Carolina Medical Centerat Chapel Hill, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Benyam Muluneh, Michele A Muir, Ashley Leak Bryant, Jennifer Elston Lafata

Förderung

  • National Center for Advancing Translational Sciences

Zitieren

APA

Muluneh, B., Muir, M. A., Collins, J. B., Proco, D., Mackler, E., Leak Bryant, A., Wood, W. A., Tilkens, M., Reichard, J. S., Foster, M., Gatwood, J., Wheeler, S. B., Zullig, L. L., & Elston Lafata, J. (2023). Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings. PLOS ONE. https://doi.org/10.1371/journal.pone.0286630

Vancouver

Muluneh B, Muir MA, Collins JB, Proco D, Mackler E, Leak Bryant A, et al. Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings. PLOS ONE. 2023. doi:10.1371/journal.pone.0286630

BibTeX
@article{Muluneh2023,
  author = {Muluneh, Benyam and Muir, Michele A and Collins, James Bernard and Proco, Darrian and Mackler, Emily and Leak Bryant, Ashley and Wood, William A and Tilkens, Michael and Reichard, Jeffrey S and Foster, Matthew and Gatwood, Justin and Wheeler, Stephanie B and Zullig, Leah L and Elston Lafata, Jennifer},
  title = {Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286630}
}
Kostenlos starten →